Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC35129105610;105611;105612 chr2:178531230;178531229;178531228chr2:179395957;179395956;179395955
N2AB33488100687;100688;100689 chr2:178531230;178531229;178531228chr2:179395957;179395956;179395955
N2A3256197906;97907;97908 chr2:178531230;178531229;178531228chr2:179395957;179395956;179395955
N2B2606478415;78416;78417 chr2:178531230;178531229;178531228chr2:179395957;179395956;179395955
Novex-12618978790;78791;78792 chr2:178531230;178531229;178531228chr2:179395957;179395956;179395955
Novex-22625678991;78992;78993 chr2:178531230;178531229;178531228chr2:179395957;179395956;179395955
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCA
  • RefSeq wild type template codon: CGT
  • Domain: Ig-164
  • Domain position: 1
  • Structural Position: 1
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/G rs1688988300 None 0.998 N 0.64 0.354 0.528712057427 gnomAD-4.0.0 2.73655E-06 None None None None N None 0 0 None 0 0 None 0 0 3.59759E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.908 likely_pathogenic 0.9051 pathogenic -1.359 Destabilizing 1.0 D 0.785 deleterious None None None None N
A/D 0.9909 likely_pathogenic 0.9923 pathogenic -2.43 Highly Destabilizing 1.0 D 0.778 deleterious None None None None N
A/E 0.9819 likely_pathogenic 0.9848 pathogenic -2.448 Highly Destabilizing 0.999 D 0.78 deleterious N 0.502733855 None None N
A/F 0.9879 likely_pathogenic 0.9907 pathogenic -1.23 Destabilizing 1.0 D 0.813 deleterious None None None None N
A/G 0.4653 ambiguous 0.4552 ambiguous -1.332 Destabilizing 0.998 D 0.64 neutral N 0.503747813 None None N
A/H 0.9931 likely_pathogenic 0.9939 pathogenic -1.333 Destabilizing 1.0 D 0.795 deleterious None None None None N
A/I 0.9757 likely_pathogenic 0.9776 pathogenic -0.563 Destabilizing 1.0 D 0.809 deleterious None None None None N
A/K 0.995 likely_pathogenic 0.9958 pathogenic -1.35 Destabilizing 1.0 D 0.787 deleterious None None None None N
A/L 0.9181 likely_pathogenic 0.9282 pathogenic -0.563 Destabilizing 0.998 D 0.733 prob.delet. None None None None N
A/M 0.9643 likely_pathogenic 0.9719 pathogenic -0.536 Destabilizing 1.0 D 0.79 deleterious None None None None N
A/N 0.9809 likely_pathogenic 0.9805 pathogenic -1.306 Destabilizing 1.0 D 0.809 deleterious None None None None N
A/P 0.6731 likely_pathogenic 0.4765 ambiguous -0.702 Destabilizing 0.64 D 0.393 neutral N 0.433700626 None None N
A/Q 0.9772 likely_pathogenic 0.9801 pathogenic -1.543 Destabilizing 1.0 D 0.825 deleterious None None None None N
A/R 0.981 likely_pathogenic 0.9858 pathogenic -0.926 Destabilizing 1.0 D 0.817 deleterious None None None None N
A/S 0.2957 likely_benign 0.2944 benign -1.537 Destabilizing 0.998 D 0.628 neutral N 0.502987344 None None N
A/T 0.7115 likely_pathogenic 0.7393 pathogenic -1.482 Destabilizing 0.999 D 0.745 deleterious N 0.492138018 None None N
A/V 0.8459 likely_pathogenic 0.8623 pathogenic -0.702 Destabilizing 0.998 D 0.678 prob.neutral N 0.485554652 None None N
A/W 0.9979 likely_pathogenic 0.9984 pathogenic -1.573 Destabilizing 1.0 D 0.8 deleterious None None None None N
A/Y 0.9938 likely_pathogenic 0.9948 pathogenic -1.186 Destabilizing 1.0 D 0.803 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.